Stocks-CLDX-Celldex Therapeutics Inc

CLDX Celldex Therapeutics Inc

36.91 2.65 (7.75%)
in USD Market Open
Invest
Invest

Overview

Prev Close34.26
Day's Range 34.45 - 37.15
52 Week Range 19.81 - 42.35
Average Volume (3m)442.86K
1-Year Return-3.52%
Beta0.9439
Market Cap1.61B
P/E Ratio
Revenue1.08M
EPS-2.2656
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Medical Or Nursing Services
CEO Anthony S. Marucci, MBA
Employees 134

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Celldex Therapeutics Inc's revenues decreased by 37.30% and amounted to 4.65M. Net income decreased by 17.95% to -70.51M. Net assets increased by 100.36% to 419.48M and EPS increased from -2.02 to -1.64.
CLDX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-1,212.20%
Operating Margin
-9,257.51%
Return On Investment
-51.88%
12/21
03/22
06/22
09/22
Total Revenue
334K
174K
163K
407K
Gross Profit
-443K
N/A
-578K
-264K
Operating Income
-20.59M
-23.79M
-27.72M
-27.7M
Net Income
-20.15M
-23.05M
-36M
-26.78M